Medannex.png

Medannex Ltd

Industrial Biotech

Phone
0131290 2674
Membership category
Corporate (1-10)

1 Lochrin Square, Fountainbridge, Edinburgh, EH3 9QA, United Kingdom

About Medannex Ltd

Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1, to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. A first-in-human clinical trial of the company’s lead molecule – a monoclonal antibody known as ‘MDX-124’ - has been initiated. In non-clinical testing MDX-124 has demonstrated multifaceted anti-cancer activity.

Therapeutic area(s)

Articles Medannex Ltd has contributed to

×
deep biotech.png

Welcome to the new BIA site!

BIA are excited to announce the soft launch of our new website!

Our team is diligently working behind the scenes to enhance your browsing experience and provide you with valuable content. During this phase, you may encounter sections that are still under construction. We kindly ask for your patience as we finalise everything.

Thank you for visiting, and we thank you for your continuous support towards BIA.